ProShares UltraShort NASDAQ Biotechnology
11 hedge funds and large institutions have $4.23M invested in ProShares UltraShort NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
4
Calls
$1.76M
Puts
–
Net Calls
+$1.76M
Net Calls Change
-$1.11M
Top Buyers
| 1 |
1
Jane Street
New York
|
$660K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$559K |
| 3 |
CT
3
CMT Trading
Chicago,
Illinois
|
$210K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$1.39M |
| 5 |
VKH
5
Virtu KCG Holdings
New York
|
$319K |
